Volume 27, Issue 4 (10-2024)
J Arak Uni Med Sci 2024, 27(4): 205-210 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Noruozi Kuma Olya R, Nasri S, Farashi-banab S, Dadfar F, Dehghani N. Investigating the Expression of Vascular Endothelial Growth Factor (VEGF) Gene Related to Angiogenesis and Interleukin-10 in Experimental Breast Tumor Model. J Arak Uni Med Sci 2024; 27 (4) :205-210
URL: http://jams.arakmu.ac.ir/article-1-7766-en.html
URL: http://jams.arakmu.ac.ir/article-1-7766-en.html
Rana Noruozi Kuma Olya1 
, Sima Nasri1 , Samad Farashi-banab2 , Fereshteh Dadfar3 
, Naeimeh Dehghani1
, Sima Nasri1 , Samad Farashi-banab2 , Fereshteh Dadfar3 , Naeimeh Dehghani1
1- Department of Biology, Payame Noor University, Tehran, Iran
2- School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3- Department of Biology, Payame Noor University, Tehran, Iran ,fereshtehdadfar2003@yahoo.com
2- School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3- Department of Biology, Payame Noor University, Tehran, Iran ,
Abstract: (3574 Views)
Introduction: Breast cancer is one of the most common cancers and the principal cause of death in women. One of the mechanisms of cancer cells for the lack of access to the immune system is the production of compounds suppressing immune responses, such as interleukin-10. On the other hand, vascular endothelial growth factor, by binding to its receptors on the surface of endothelial cells, plays a significant role in vascular permeability and tumor vascularity. In this study, the expression of interleukin-10 and vascular endothelial growth factor in breast tumor tissue was investigated in an experimental tumor model.
Methods: First, mammary tumors were experimentally induced in Balb/C mice, and RNA was extracted from the tumor tissue. cDNA was synthesized from the extracted RNAs, and the expression level of 10-IL and VEGF genes was evaluated by RT-PCR.
Results: The results of data analysis showed that the expression of IL-10 and VEGF genes in the tumor tissue was higher than in the cells of the control group, but this increase in expression was not statistically significant.
Conclusions: In general, the expression level of Interleukin-10 and VEGF genes was increased in the experimental tumor model, but broader research and the correlation with other involved factors seem necessary.
Methods: First, mammary tumors were experimentally induced in Balb/C mice, and RNA was extracted from the tumor tissue. cDNA was synthesized from the extracted RNAs, and the expression level of 10-IL and VEGF genes was evaluated by RT-PCR.
Results: The results of data analysis showed that the expression of IL-10 and VEGF genes in the tumor tissue was higher than in the cells of the control group, but this increase in expression was not statistically significant.
Conclusions: In general, the expression level of Interleukin-10 and VEGF genes was increased in the experimental tumor model, but broader research and the correlation with other involved factors seem necessary.
Type of Study: Original Atricle |
Subject:
Basic Sciences
Received: 2024/07/24 | Accepted: 2024/10/27
Received: 2024/07/24 | Accepted: 2024/10/27
References
1. Anastasiadi Z, Lianos GD, Ignatiadou E, Harissis HV, Mitsis M. Breast Cancer in Young Women: An Overview. Updates Surg. 2017;69:313-7. pmid: 28260181 doi: 10.1007/s13304-017-0424-1
2. Mubarik S, Wang F, Fawad M, Wang Y, Ahmad I, Yu C. Trends and projections in breast cancer mortality among four Asian Countries (1990-2017): evidence from five stochastic mortality models. Sci Rep. 2020;10:5480. pmid: 32214176 doi: 10.1038/s41598-020-62393-1
3. Oblak T, Zadnik V, Krajc M, Lokar K, Zgajnar J. Breast cancer risk based on adapted ibis prediction model in slovenian women aged 40- 49 years - could it be better? Radiol. Oncol. 2020;54:335–40. pmid: 32614783 doi: 10.2478/raon-2020-0040
4. Mohamed H.T, El-Husseiny N, El-Ghonaimy E.A, Ibrahim S.A, et al. IL-10 Correlates with the Expression of Carboxypeptidase B2 and Lymphovascular Invasion in Inflammatory Breast Cancer: The Potential Role of Tumor Infiltrated Macrophages. Curr Probl Cancer. 2018;42(2):215–30. pmid: 29459177 doi: 10.1016/j.currproblcancer.2018.01.009
5. Carpi A, Nicolini A, Antonelli A, Ferrari P and Rossi G. Cytokines in the management of high risk or advanced breast cancer: an update and expectation. Curr. Cancer Drug Targets. 2009;9(8):888-903. pmid: 20025599 doi: 10.2174/156800909790192392
6. Korkaya H, Liu S, Wicha MS. Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J Clin Invest. 2011;121(10):3804-9. pmid: 21965337 doi: 10.1172/JCI57099
7. Vacchelli E, Aranda F, Obrist F, Eggermont A, Galon J, Cremer I, et al. Trial watch: immunostimulatory cytokines in cancer therapy. Oncoimmunology. 2014;3(6):290-94. pmid: 25083328 doi: 10.4161/onci.29030
8. Li L, Xiong W, Li D, Cao J. Association of Interleukin-10 Polymorphism (rs1800896, rs1800871, and rs1800872) With Breast Cancer Risk: An Updated Meta-Analysis Based on Different Ethnic Groups. Front. Genet. 2022;13:829283. pmid: 35186043 doi: 10.3389/fgene.2022.829283
9. Sheikhpour E, Noorbakhsh P, Foroughi E, et al. A survey on the role of interleukin-10 in breast cancer: a narrative. Rep Biochem Mol Biol. 2018;7(1):30-7. pmid: 30324115
10. Pournemati P, Hooshmand Moghadam. The effect of 12 weeks of interval and continuous training on serum levels of interleukin-17 and interleukin-10 in postmenopausal breast cancer survivors: a clinical trial [in Persian]. Iranian Journal of Breast Diseases. 2021;14(2):4-15. doi: 10.30699/ijbd.14.2.4
11. Ferrara N. VEGF and the quest for tumor angiogenesis factors. Nature Reviews Cancer 2002;2(10): 795-803. pmid: 12360282 doi: 10.1038/nrc909
12. .Shibuya M. Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis. Angiogenesis. 2006;9(4):225-30. pmid: 17109193 doi: 10.1007/s10456-006-9055-8
13. Koch S, Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med. 2012;2(7):a006502. pmid: 22762016 doi: 10.1101/cshperspect.a006502
14. Senger DR. Vascular endothelial growth factor: much more than an angiogenesis factor. Mol Biol Cell. 2010; 21(3):377-9. pmid: 20124007 doi: 10.1091/mbc.E09-07-0591
15. Yaqoob U, Cao S, Shergill U, Jagavelu K, et al. Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment. Cancer Res. 2012;72(16):4047-59. pmid: 22738912 doi: 10.1158/0008-
16. CAN-11-3907
17. Goel H.L, Mercurio A.M. VEGF targets the tumor cell. Nat Rev Cancer.2013; 13(12):871-882.
18. Berti FCB, de Oliveira KB. IL-10 in cancer: Just a classical immunosuppressive factor or also an immunostimulant one? AIMS Allergy and Immunology. 2018; 2(2):88-97. doi: 10.3934/Allergy.2018.2.88
19. Garcia-Hernández ML, Hernandez-Pando R, Gariglio P, Berumen J. Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation. Immunology. 2002; 105(2):231–43. pmid: 11872099 doi: 10.1046/j.1365-2567.2002.01363.x
20. Hedrich CM, Bream JH. Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol Res. 2010;47(1-3):185-206. pmid: 20087682 doi: 10.1007/s12026-009-8150-5
21. Segal BM, Glass DD, Shevach EM. Cutting Edge: IL- 10-producing CD4+ T cells mediate tumor rejection. J Immunol. 2002;168(1):1-4. pmid: 11751938 doi: 10.4049/jimmunol.168.1.1
22. Kohno T, Mizukami H, Suzuki M, Saga Y, Takei Y, Shimpo M, et al. Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer. Cancer Res. 2003;63(16):5091-4. pmid: 12941839
23. Ma T, Kong M. Interleukin 18 and 10 may be associated with lymph node metastasis in breast cancer. Oncol Lett. 2021;21(4):253. pmid: 33664817 doi: 10.3892/ol.2021.12515
24. Bolat F, Kayaselcuk F, Nursal TZ, Yagmurdur MC, Bal N, Demirhan B. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters. J Exp Clin Cancer Res. 2006;25(3):365-72. pmid: 17167977
25. Farzaneh Behelgardi M, Zahri S, Mashayekhi F, Asghari SM. The effect of vascular endothelial growth factor antagonist peptide (VGB4) on breast tumor growth suppression in vivo [in Persian]. Armaghane-Danesh. 2019;23(6):683-93.
26. Ricci-Vitiani L, Pallini R, Biffoni M. Tumour vas-cularization via endothelial differentiation of glioblastoma stem-like cells. Nature. 2010; 468(7325):824–8. pmid: 21102434 doi: 10.1038/nature09557
27. de Laporte L, des Rieux A, Tuinstra HM, Zelivyanskaya ML, De Clerck NM, Postnov AA, et al. Vascular endothelial growth factor and fibroblast growth factor 2 delivery from spinal cord bridges to enhance angiogenesis following injury. J Biomed Mater Res A. 2011;98(3):372–82. pmid: 21630429 DOI: 10.1002/jbm.a.33112
28. Ramezani T, Baharaa J. A review on angiogenesis in tumor [in Persian]. Journal of Cell & Tissue. 2014;5(1):89-100. doi: 10.52547/JCT.5.1.89
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
